Biomarkers of Patients with Non-small Cell Lung Cancer who Benefited from Erlotinib Treatment
Main Authors: | Dali HAN, Jinmimg YU |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2009-12-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2009.12.27&path[]=1251 |
Similar Items
-
The Analysis of Erlotinib on Brain Metastases in Patients with Non-small-cell Lung Cancer
by: Baohui HAN, et al.
Published: (2009-12-01) -
Erlotinib in Patients with Brain Metastases for Non-small Cell Lung Cancer
by: Jinming YU, et al.
Published: (2009-12-01) -
Progression in Therapy of Erlotinib for Patients with Non-small Cell Lung Cancer
by: Li MA, et al.
Published: (2009-12-01) -
Clinical Observation of Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer: A Report of 92 Eases
by: Baohui HAN, et al.
Published: (2009-12-01) -
Erlotinib in the Second/Third Line Treatment of Patients with Advanced Non-small Cell Lung Cancer
by: Yilong WU, et al.
Published: (2009-05-01)